We updated the design of this site on September 25th. Learn more.

Rationales for Wound Care Management in Old World Cutaneous Leishmaniasis Patients (LEICO)

This study has been completed.

Sponsor:

ClinicalTrials.gov Identifier:

NCT00996463

First Posted: October 16, 2009

Last Update Posted: March 28, 2011

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

Collaborators:

German Federal Ministry of Education and Research

Heidelberg University

University of Erlangen-Nürnberg Medical School

Information provided by:

Waisenmedizin e. V. Promoting Access to Essential Medicine

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	March 2011
Primary Completion Date:	September 2010 (Final data collection date for primary outcome measure)

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Stahl HC, Ahmadi F, Schleicher U, Sauerborn R, Bermejo JL, Amirih ML, Sakhayee I, Bogdan C, Stahl KW. A randomized controlled phase IIb wound healing trial of cutaneous leishmaniasis ulcers with 0.045% pharmaceutical chlorite (DAC N-055) with and without bipolar high frequency electro-cauterization versus intralesional antimony in Afghanistan. BMC Infect Dis. 2014 Nov 25;14:619. doi: 10.1186/s12879-014-0619-8.

To Top